Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: Results of an eastern cooperative oncology group trial

Philip Bonomi*, Kyung Mann Kim, Diane Fairclough, David Cella, John Kugler, Eric Rowinsky, Michael Jiroutek, David Johnson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

553 Scopus citations

Fingerprint

Dive into the research topics of 'Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: Results of an eastern cooperative oncology group trial'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience